Home / Inspections / 1052720

FDA Inspection 1052720 — Sciegen Pharmaceuticals Inc

Sciegen Pharmaceuticals Inc — FEI 3008298016

The FDA completed an inspection of Sciegen Pharmaceuticals Inc on April 20, 2018 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hauppauge, NY (United States)

Facility

Other inspections at this facility

  • 1317246 (VAI Fri May 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1297968 (NAI Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229682 (NAI Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1204858 (OAI Fri Apr 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1178870 (VAI Fri Sep 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources